Skip Navigation

We value your privacy. Your user session will expire in 2 minutes. To stay logged in, please refresh the page or, if you are working
on a form, click on the submit button to save your work. Click here to refresh now (you will lose any unsaved work).

Recommendation Angiogenesis in First Line Advanced NSCLC: Focus on Avastin (Bevacizumab)

Updated Jan 6, 2010, filed in All Journey Phases, Lung Cancer
Video presentation describing the concept behind angiogenesis and the evidence on the anti-angiogenic agent avastin (bevacizumab) in NSCLC.